IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q1 2022 Holdings

Filed 2022-05-16 | 38 holdings | $4.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Moderna Inc(MRNA)COM60770K107$3.0M17,581,01671.1%
Sana Biotechnology Inc(SANA)COM799566104$282.8K34,239,0186.6%
Rubius Therapeutics IncCOM78116T103$212.2K38,506,5265.0%
Foghorn Therapeutics Inc(FHTX)COM344174107$193.0K12,674,1204.5%
Omega Therapeutics IncCOM68217N105$161.6K25,902,2693.8%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$102.4K14,378,8022.4%
Denali Therapeutics Inc(DNLI)COM24823R105$84.3K2,619,9682.0%
Evelo Biosciences IncCOM299734103$78.1K23,030,0691.8%
Axcella Health IncCOM05454B105$48.5K18,867,7851.1%
Kaleido Biosciences Inc(KLDO)COM483347100$32.3K19,575,7100.8%
Codiak Biosciences Inc(32W)COM192010106$16.3K2,607,3030.4%
Sigilon Therapeutics IncCOM82657L107$15.2K10,370,3690.4%
Syros Pharmaceuticals IncCOM87184Q107$3.5K2,938,4940.1%